<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28303920</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2017</Year><Month>Mar</Month><Day>17</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The Golgi protein ACBD3 facilitates Enterovirus 71 replication by interacting with 3A.</ArticleTitle><Pagination><StartPage>44592</StartPage><MedlinePgn>44592</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">44592</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep44592</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a human pathogen that causes hand, foot, mouth disease and neurological complications. Although EV71, as well as other enteroviruses, initiates a remodeling of intracellular membrane for genomic replication, the regulatory mechanism remains elusive. By screening human cDNA library, we uncover that the Golgi resident protein acyl-coenzyme A binding domain-containing 3 (ACBD3) serves as a target of the 3A protein of EV71. This interaction occurs in cells expressing 3A or infected with EV71. Genetic inhibition or deletion of ACBD3 drastically impairs viral RNA replication and plaque formation. Such defects are corrected upon restoration of ACBD3. In infected cells, EV71 3A redirects ACBD3, to the replication sites. I44A or H54Y substitution in 3A interrupts the binding to ACBD3. As such, viral replication is impeded. These results reveal a mechanism of EV71 replication that involves host ACBD3 for viral replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;Peking Union Medical College, Beijing P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;Peking Union Medical College, Beijing P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhenzhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;Peking Union Medical College, Beijing P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yijie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, University of Illinois, Chicago, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Jianli</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;Peking Union Medical College, Beijing P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;Peking Union Medical College, Beijing P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;Peking Union Medical College, Beijing P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhuo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;Peking Union Medical College, Beijing P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, University of Illinois, Chicago, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;Peking Union Medical College, Beijing P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hanzhou 310003, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI112755</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C449459">ACBD3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C120445">GBF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020662">Guanine Nucleotide Exchange Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020823">ADP-Ribosylation Factor 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020823" MajorTopicYN="N">ADP-Ribosylation Factor 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006056" MajorTopicYN="N">Golgi Apparatus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020662" MajorTopicYN="N">Guanine Nucleotide Exchange Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>3</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28303920</ArticleId><ArticleId IdType="pmc">PMC5356004</ArticleId><ArticleId IdType="doi">10.1038/srep44592</ArticleId><ArticleId IdType="pii">srep44592</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C. C. et al.. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 341, 936&#x2013;942 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. et al.. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 10, 778&#x2013;790 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W. et al.. Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis. 14, 308&#x2013;318 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N. J., Lennette E. H. &amp; Ho H. H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 129, 304&#x2013;309 (1974).</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L. G. et al.. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 31, 678&#x2013;683 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M. et al.. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 341, 929&#x2013;935 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L. &amp; Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 32, 236&#x2013;242 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Cui S., Zhao Z. &amp; Wang J. Etiology, pathogenesis, antivirals and vaccines of hand, foot, and mouth disease. Natl Sci Rev. 2, 268&#x2013;284 (2015).</Citation></Reference><Reference><Citation>Lei X., Xiao X. &amp; Wang J. Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction. Viruses. 8, 22; 10.3390/v8010022 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010022</ArticleId><ArticleId IdType="pmc">PMC4728582</ArticleId><ArticleId IdType="pubmed">26784219</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 26, 91&#x2013;107 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu N. Y. et al.. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 141, 799&#x2013;811 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W. F. et al.. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J Biol Chem. 282, 5888&#x2013;5898 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17182608</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A. L. Picornavirus-host interactions to construct viral secretory membranes. Prog Mol Biol Transl Sci. 129, 189&#x2013;212 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25595805</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H. et al.. Human Enterovirus Nonstructural Protein 2CATPase Functions as Both an RNA Helicase and ATP-Independent RNA Chaperone. PLoS Pathog. 11, e1005067 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4517893</ArticleId><ArticleId IdType="pubmed">26218680</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Takebe Y., Wakita T. &amp; Shimizu H. A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection. J Gen Virol. 91, 2734&#x2013;2744 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20660150</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q. et al.. Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A. Antimicrob Agents Chemother. 59, 2654&#x2013;2665 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394834</ArticleId><ArticleId IdType="pubmed">25691649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa-Sasaki K., Sasaki J. &amp; Taniguchi K. A complex comprising phosphatidylinositol 4-kinase IIIbeta, ACBD3, and Aichi virus proteins enhances phosphatidylinositol 4-phosphate synthesis and is critical for formation of the viral replication complex. J Virol. 88, 6586&#x2013;6598 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4054359</ArticleId><ArticleId IdType="pubmed">24672044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E. et al.. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell. 11, 191&#x2013;201 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16890159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E. et al.. Molecular determinants of the interaction between coxsackievirus protein 3A and guanine nucleotide exchange factor GBF1. J Virol. 81, 5238&#x2013;5245 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900206</ArticleId><ArticleId IdType="pubmed">17329336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E. et al.. Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment. J Virol. 80, 11852&#x2013;11860 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1642585</ArticleId><ArticleId IdType="pubmed">17005635</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov G. A., Kovtunovych G., Jackson C. L. &amp; Ehrenfeld E. Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1. Cell Microbiol. 12, 1463&#x2013;1479 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2945620</ArticleId><ArticleId IdType="pubmed">20497182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanke K. et al.. GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J Virol. 83, 11940&#x2013;9 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772713</ArticleId><ArticleId IdType="pubmed">19740986</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorobantu C. M. et al.. GBF1- and ACBD3-independent recruitment of PI4KIII beta to replication sites by rhinovirus 3A proteins. J Virol. 89, 1913&#x2013;1918 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300732</ArticleId><ArticleId IdType="pubmed">25410869</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorobantu C. M. et al.. Recruitment of PI4KIII&#x3b2; to coxsackievirus B3 replication organelles is independent of ACBD3, GBF1, and Arf1. J Virol. 88, 2725&#x2013;2736 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3958084</ArticleId><ArticleId IdType="pubmed">24352456</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoule F. et al.. The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication. J Virol. 87, 11031&#x2013;11046 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807280</ArticleId><ArticleId IdType="pubmed">23926333</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar H. M. et al.. Coxsackievirus mutants that can bypass host factor PI4KIII beta and the need for high levels of PI4P lipids for replication. Cell Res. 22, 1576&#x2013;1592 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3494396</ArticleId><ArticleId IdType="pubmed">22945356</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut H. J. et al.. Fitness and virulence of a coxsackievirus mutant that can circumnavigate the need for phosphatidylinositol 4-kinase class III beta. J Virol. 88, 3048&#x2013;3051 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3958056</ArticleId><ArticleId IdType="pubmed">24371067</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards A. L., Soares-Martins J. A., Riddell G. T. &amp; Jackson W. T. Generation of unique poliovirus RNA replication organelles. MBio. 5, e00833&#x2013;00813 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3940031</ArticleId><ArticleId IdType="pubmed">24570367</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki J., Ishikawa K., Arita M. &amp; Taniguchi K. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J. 31, 754&#x2013;766 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A. L., Knudsen G. M., Betegon M., Burlingame A. L. &amp; Derisi J. L. The 3A protein from multiple picornaviruses utilizes the golgi adaptor protein ACBD3 to recruit PI4KIIIbeta. J Virol. 86, 3605&#x2013;3616 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302542</ArticleId><ArticleId IdType="pubmed">22258260</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A. L., Knudsen G. M., Betegon M., Burlingame A. L. &amp; DeRisi J. L. ACBD3 interaction with TBC1 domain 22 protein is differentially affected by enteroviral and kobuviral 3A protein binding. MBio. 4, e00098&#x2013;00013 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622926</ArticleId><ArticleId IdType="pubmed">23572552</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Du J. &amp; Jin Q. Class I ADP-ribosylation factors are involved in enterovirus 71 replication. PLoS One. 9, e99768 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049829</ArticleId><ArticleId IdType="pubmed">24911624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z. et al.. Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China. J Virol Methods. 159, 233&#x2013;238 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19490979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. et al.. Reciprocal Regulation between Enterovirus 71 and the NLRP3 Inflammasome. Cell Rep. 12, 42&#x2013;48 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26119741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X. et al.. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol. 84, 8051&#x2013;8061 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Z., Yang X., Yang G. &amp; Zhang L. Hepatitis C virus NS5A competes with PI4KB for binding to ACBD3 in a genotype-dependent manner. Antiviral Res. 107, 50&#x2013;5 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24792752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z. et al.. TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response. Proc Natl AcadSci USA. 111, E245&#x2013;254 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896185</ArticleId><ArticleId IdType="pubmed">24379373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y. X., Xu Y., Ou Z. Y., Su L. &amp; Xia H. M. A simple and highly repeatable viral plaque assay for enterovirus 71. J Basic Microbiol. 55, 538&#x2013;41 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25515071</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z. et al.. Fragile X mental retardation protein stimulates ribonucleoprotein assembly of influenza A virus. Nat Commun. 5, 3259 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24514761</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Z. et al.. Crystal structure of 2A proteinase from hand, foot and mouth disease virus. J Mol Biol. 425, 4530&#x2013;4543 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23973886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. X. et al.. Construction and characterization of an infectious cDNA clone of enterovirus type 71 subgenotype C4. Virus Genes. 47, 235&#x2013;243 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23877719</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>